-
-
-
-
-
-
-
Halozyme Therapeutics (HALO) Confirms Proposal to Combine with Evotec (EVO) for €11.00 Per Share in an All-Cash Transaction
-
-
-
-
-
-
-
Results of Joint Special Shareholder Meeting of Certain Eaton Vance Closed-End Funds
-
-
-
-
-
-
-
Evotec Launches INDIGO, A Unique Integrated Drug Development Solution for Accelerating Early Drug Candidates into the Clinic
-
-
-
-
-
-
-
Evotec AG to Acquire Aptuit
-
-
-
-
-
-
-
Evotec Completes Acquisition of Cyprotex PLC
-
-
-
-
-
-
-
Evotec FY 2015: Excellent Execution Meets First-in-Class Innovation
-
-
-
-
-
-
1,155,357 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

